Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Change in Account Payables (2017 - 2025)

Aclaris Therapeutics has reported Change in Account Payables over the past 9 years, most recently at $4.0 million for Q4 2025.

  • Quarterly results put Change in Account Payables at $4.0 million for Q4 2025, up 233.34% from a year ago — trailing twelve months through Dec 2025 was $8.4 million (up 301.7% YoY), and the annual figure for FY2025 was $8.4 million, up 301.7%.
  • Change in Account Payables for Q4 2025 was $4.0 million at Aclaris Therapeutics, up from $377000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for ACRS hit a ceiling of $4.0 million in Q4 2025 and a floor of -$3.5 million in Q2 2024.
  • Median Change in Account Payables over the past 5 years was $1.0 million (2024), compared with a mean of $340450.0.
  • Biggest five-year swings in Change in Account Payables: soared 931.44% in 2021 and later plummeted 654.31% in 2024.
  • Aclaris Therapeutics' Change in Account Payables stood at $2.4 million in 2021, then rose by 13.76% to $2.7 million in 2022, then crashed by 114.66% to -$394000.0 in 2023, then plummeted by 654.31% to -$3.0 million in 2024, then surged by 233.34% to $4.0 million in 2025.
  • The last three reported values for Change in Account Payables were $4.0 million (Q4 2025), $377000.0 (Q3 2025), and $2.4 million (Q2 2025) per Business Quant data.